Hyaluronan fibres, method of preparation thereof and use thereof

Field of the invention
The present invention relates to a method for preparing hyaluronic fibres by the wet and dry-wet spinning processes, further it relates to the fibres preparable by this method having the properties appropriate for textile processing.
Background of the Invention
Hyaluronic acid (A) has the chemical structure of a linear polyelectrolyte composed of repeatedly altering units of -(1 ,3)-D-glucuronic acid and p-(1 ,4)-N-acetyl-D-glukosamine repeating continually and creating long chains . Every repeating unit has one carboxyl group, four hydroxyl groups, and an acetarnide group.
Primary and secondary hydroxyl groups are moderately acidic, and they can be ionized by alkali ionization, for example sodium hydroxide, where, however, pK a is above the value of 14 . The carboxyl group is from the group of medium acids, neutralized by alkali into salts, hylauronates, e.g. sodium hyaluronate. The mixture of the salt and free acid is referred as hyaluronan. For example, pK a of the free form of hyaluronic acid in water varies around 3.45, in 0.2M NaCI it is 2.95 (L. Lapcik et al.: Chemicke listy 85, 281-298, 1991 ) .
Hyaluronic acid is characterized by high molecular weight of 5 . 10 4 to 5 .10 6 g.mol " 1 depending on the source from which it has been obtained. This polysaccharide is soluble in water in the whole pH range, in the form of a salt.
Hyaluronic acid is a unique biopolymer intended for therapeutic applications acknowledged as a versatile surface material improving the biocompatibility of remedies. A review can be found for example in the publication (S. Dumitriu, Polysaccharides: Structural diversity and functional versatility, Marcel Dekker Inc. 1998 , ISBN 0824701 275).
Polysaccharides do not flux but for preparation of fibres, the wet spinning can be successfully used where the polysaccharide solution in a proper solvent is extruded through various types of nozzles (circular nozzle or slot nozzle or a nozzle of various cross-sections: star-snapea, spherical triangle, and the like) directly into a non-solvent (precipitation bath) where a fibre or a film is formed. The wet spinning can be modified into the so-called dry-wet spinning. It is used for example for the spinning of some kinds of aromatic polyamides or fibres made of regenerated cellulose of the types of Tencell, Lyocell, and the like. The principle of the dry-wet spinning consists in that a polymer solution stream leaving the nozzle passes through an air gap of the length within the range between a few millimetres to a few centimetres, before it enters the precipitation bath (this The methods of hyaluronic acid spinning into a fibre are known, for example A . Rupprecht (Acta Chem. Scand., B33, No. 10, 1979) spun the potassium salt of the hyaluronic acid in 75 to 80% ethanol comprising 0.1M KCI, where fibres were coiled into a disc so that they agglutinated by drying into a film comprising "spatially oriented" hyaluronic acid. This way of spinning naturally did not lead to fibres which would be possible to process in the textile industry.
Further, E.D.T. Atkins et al. (Biochem. J . 128, 1255 -1263 , 1972 ) prepared model fibres of hyaluronic acid and sodium hyaluronate in such a way that first a film was prepared, which was then cut to thin strips. At these "model fibres" cut from the films (and drawn) they determined the crystal modification (including the diameters of an elementary crystal cell) by means of an X-ray structure analysis. They found out that the non-drawn sodium hyaluronate fibre had an elementary cell of the hexagonal crystal system and macromolecules arranged in an antiparallel way, supposing the presence of hydrogen bonds between amid groups of acetylated glukosamine. Base dimensions: a = 1.17 nm (alternatively 2.02 nm). The macromolecule average cross-section dimension approx. 0.673 nm. Dimension c of the elementary cell (along the fibre axis) was 2.85 nm.
They further found out that conditioning of the sodium hyaluronate based fibres at 60°C and relative humidity of 75 % lead to formation of a new hexagonal crystal lattice, a = 1.87 maintaining c = 2.85 nm. The change of the lattice system (maintaining the crystal modification)
is known also in case of other fibres -polymers -e.g. celulose in a cotton fibre.
The same author determined a monoclinic crystal system with an elementary cell diameter of a = 1.96 nm (however, it is not fully defined) of fibres prepared form hyaluronic acid (acidic form).
Due to the fact that hyaluronates being highly hygroscopic and soluble in water, the spatial formations are of low resistance against water which is the main technical problem in manufacturing of fibres (both micro-and nanofibres), yarn, non-woven fabrics, scaffolds, membranes, and the like.
The technical solution of this problem consists in using less soluble derivatives of hyaluronic acid, usually esters (e.g. US Patents 4, 851 , 521; 4, 965, 353 a 5, 676, 964) , and preparing usually non-woven fabrics (for example US Patent 5, 520, 916) . A part of carboxyl groups of hyaluronic acid or all of the groups are esterified (HA-COOH → HA-COOR).
For example US Patent 5824335 describes the preparation of non-woven fabrics from the esters of hyaluronic acid , especially from benzylester. .
Further, for example 98/08876 describes preparation of a yarn from the esters of hyaluronic acid. For example a tetrabutylammonium salt of hyaluronic acid is solved in DMSO (dimethylsufoxide) together with PhCH 2 Br and an alkylation reaction is carried out resulting in the formation of an ester being spun from this DMSO solution into the yarn which has more of the so-called elementary fibres.
Using of esters leads to blocking of a carboxyl and thus changing the spatial arrangement of fibres. Hyaluronidase enzyme afinity to hyaluronate and its biological properties are changed as well.
When studying polysaccharides and their modifications, their structure which they assume in either polar or non-polar environments should not be neglected. Hyaluronan is practically insoluble in non-polar solvents; This chemistry is associated with the so-called supramolecular chemistry. The inner structure of polysaccharide should be known because, under influence of mainly inner and outer hydrogen bonds, the polymer assumes a particular secondary and tertiary structure in an environment. The hydrogen bonds are weak but considering the fact that they can be established in a great amount per every unit of for example hyaluronic acid, it is obvious that very complex spatial formations are established where the individual molecules are knotted together and wrapped in themselves. The molecules of the solvent (for example water) also bond onto the polysaccharide by means of hydrogen bonds resulting in bulking and enlarging of the polysaccharide volume after its inserting in water.
Hyaluronate bonds a large amount of water onto itself very strongly. A Donati et al. (Biopolymers 59, 434.445, 2001 ) describe that in fact, the hydrogen bond between the carboxylate group and the acetamide group is mediated by the water molecule.
There is a very interesting fact that the activity coefficient value of the Na+ cation (of 0.7 to 0.8.)
implies that very few carboxyl groups bond sodium ions (carboxyl groups are blocked with the hydrogen bond). As every monomer unit of hyaluronic acid comprises one carboxyl group, then it theoretically should be perfectly soluble in water forming solutions of low viscosity. However, this is not true. Even the solutions with low concentration of hyaluronic acid, or hylauronane respectively, have high viscosity.
The Jacoboni study (Journal of Structural Biology 126, 52-58, 1999) states that a threedimensional network (molecular weight 2 MDa) is established in water at the concentrations of hyaluronic acid above 1 mg/ml. By drying, a network is formed again but the quality of this network depends on the drying speed. However, they formed this network on a graphite or daze preferably within the range of 1 to 2 wt. % ; b) extruding the solution through a nozzle into the spinning bath; c) forming of the fibre in the bath consisting of acetic acid and water, where the acetic acid concentration is higher than 80 % , preferably 90 % , more preferably 99 % . The obtained yarn has a diameter higher than 100 µ η . Authors of this document state that the fibres prepared according to their process can be used for both woven and non-woven textiles.
In fact, they are not usable for preparing the fabrics or knitted fabrics due to their low strength (according to the comparative example 10, the break occurs at loading of about 67 MPa), so they are usable only for preparing the non-woven textiles. The textile fibres made by standard methods have the strength within following ranges: celulose fibres: 1.8 to 2.7 cN.dtex ; synthetic fibres 4 cN.dtex ' 1 ; coefficient of variation up to 0 % .
The present invention thus removes this absence of tenacious hyaluronan fibres on the market, intended for the preparation of woven fabrics and knitted fabrics by means of common textile processes: weaving, knitting, bobbin lace work -both manual and mechanical, preparation of non-woven textiles especially by fleece strengthening, e.g. needle punching.
Loop (knot) strength of the fibre should be approximately 80% of the fibre strength without deformation. This is especially important for weaving, knitting, and bobbin lace work. For nonwoven textiles, the loop strength of the fibre is not crucial.
Summary of the Invention
The object of the invention is the method for preparing fibres based on hyaluronic acid and/or its metal compounds, where the subject-matter of said method consists in that the spinning solution comprising hyaluronic acid and/or its metal compound is prepared and then spun in the coagulation (precipitation) bath comprising an alcohol and an acid, then the fibre is washed and after washing it is dried.
The method according to the invention is carried out in the following way: first a spinning aqueous solution of hyaluronic acid and/or metal compound of hyaluronic acid comprising 0.001 to 10 N of a base and 0.01 to 8 wt. % of hyaluronic acid and/or its metal compound is prepared; then the solution is spun by a nozzle into the coagulation bath comprising 1 to 99 wt. % of alcohol, 1 to 99 wt. % of acid and not more than 0 wt. % of water, then the fibre is washed with alcohol and dried.
Preferably, after the spinning in the coagulation bath, at least one step selected from the group comprising maturing the fibre in the coagulation bath and drawing the fibre can be carried out.
The spinning solution according to one embodiment of the invention comprises hyaluronic acid and/or its metal compound and a base selected from the group comprising LiOH, NaOH, KOH, Li 2 C0 3 , Na 2 C0 3 , K 2 C0 3 , LiHC0 3 , NaHC0 and KHC0 , the coagulation bath comprises an alcohol selected from the group comprising methanol, ethanol, 1-propanol and 2-propanol, and an acid selected from the group comprising formic acid, acetic acid, propionic acid, or their mixture, the washing is carried out by immersing into an alcohol bath or by washing with an alcohol, where the alcohol is selected from the group comprising methanol, ethanol, 1-propanol and 2-propanol, and the drying is carried out by standing in air or in nitrogen or C0 atmosphere In another embodiment the spinning solution can further comprise a metal salt. Any amount of the metal salt can be added up to the maximum amount soluble in the said solution, whereas the amount of a transitional metal can by maximally 10 mg/1 kg of the total amount of hyaluronic acid and its metal compound to avoid hyaluronate crosslinking resulting in forming a gel which cannot be spun. A suitable salt can be a metal salt which is soluble in water under neutral or alkali conditions, preferably a salt comprising metal cations selected from the group comprising Li*, Na * , K * , Ca + , Mg 2* , Cr 3* , Mn 2 * , Fe 2 * , Fe 3* , Co 2 * , Co 3* , Cu 2* , Zn 2* and mixtures thereof. The metal salts are preferably selected from the group comprising hydroxides, carbonates, bicarbonates, acetates, formates, chlorides, sulphates, fluorides, nitrates, and hydrates of these salts. In this embodiment of the invention, the spinning solution is preferably prepared in the following was: first the solution of a base selected form the group comprising LiOH, NaOH, KOH, Li 2 C0 , Na 2 C0 3 , K 2 C0 3 , LiHC0 3 , NaHC0 3 and KHC0 3 , with the concentration of the base of 0.001 to 10 N is prepared, and into this solution, hyaluronic acid and/or its metal compound is gradually added while mixing, so that a solution of the concentration of 0.01 to 8 wt. % of hyaluronic acid and/or its metal compound is formed. Then a metal salt is added into this solution so that the total amount of transitional metals is not more than 10 mg per 1 kg of hyaluronate, forming a solution of a compound comprising hyaluronic acid and metal ions, which is then stirred for 20 minutes to 10 hours at the temperature of 18 to 35 ' C until a homogeneous solution suitable for spinning is formed. This solution can be prepared under ambient atmosphere or further preferably under inert atmosphere, e.g. nitrogen or argon. Preferably, a fibre is left to stand in the coagulation bath after being spun. Preferably, the fibre is drawn after spinning or its leaving to stand in the coagulation bath.
The term "compound comprising hyaluronic acid and metal ions", as used herein, comprises any compound comprising hyaluronic acid and metal or non-metal ions including salts and metal complex compounds. The nature of the bond between the metal ion and hyaluronic acid depends on the metal, usually it is an ionic bond, covalent bond (ionic-covalent) or coordinate covalent bond. The said term also includes compounds comprising ions of more than one metal.
The metals are preferably selected from the group comprising lithium, sodium, potassium, calcium, magnesium, copper, manganese, zinc, chromium, iron, and cobalt.
In another embodiment the coagulation bath can further comprise one or more metal salts. A suitable salt can be a metal salt soluble in the coagulation bath, preferably a salt comprising metal cations selected from the group comprising Li + , Na + , K + , Ca 2+ , Mg 2+ , Cr + , n + , Fe 2 , Fe 3 , Co + , Co + , Cu 2 , Zn 2+ and mixtures thereof. The metal salts are selected preferably from the group comprising hydroxides, carbonates, bicarbonates, acetates, formates, chlorides, sulphates, fluorides, nitrates, and hydrates of these salts, within the concentration of 0.01 to 10 N . In one preferred embodiment the coagulation bath contains a solution of metal(s) (e.g. Ca + )
in the mixture of 5 to 95 wt. % of alcohol, 5 to 95 wt. % of acid, and maximally 0 wt. % of water.
In another embodiment, the washed fibre or the washed and dried fibre, drawn or preferably non-drawn, based on hyaluronic acid and/or its metal compound, can be immersed into a as follows: the washed fibre or the washed and dried fibre, drawn or preferably non-drawn, based on hyaluronic acid and/or its metal compound is introduced into a metallization bath, which enables incorporating of other metals into the fibre after the fibre is washed and dried.
The fibre is left in the metallization bath for 20 minutes to 2 1 days.
In another embodiment, the spinning solution can comprise 0.001 to 10 N of base, 0.01 to 8
wt. % of hyaluronic acid and/Or its metal compound and compounds come from hyaluronic acid fibres already prepared, dissolved in the spinning bath comprising a metal selected from the group comprising LP, Na K * . Ca + , Mg 2+ , Mn 2 , Fe + , Fe + , Co 2+ , Co , Cu 2* , Zn + , where the amount of transitional metals in the spinning bath is not more than 10 mg per 1 kg of hyaluronan totally introduced, as these polyvalent ions can at a higher concentration crosslink the hyaluronic acid to a gel which cannot be spun.
In this embodiment of the invention the spinning solution is preferably prepared in the following way: first the solution of a base selected from the group comprising LiOH, NaOH, KOH, Li 2 C0 3 , Na C0 3 , K 2 C0 , HC 3 , NaHC0 3 and KHCO 3 , of the base concentration of 0.001 to 10 N is prepared, and into this solution, the compound comprising hyaluronic acid and metal ions and/or hyaluronic acid and/or its metal compound is gradually added, i.e. the fibres, already prepared, of hyaluronic acid with metal content, so that a solution of the concentration of 0.01 to 8 wt. % of compound comprising hyaluronic acid and metal ions and/or hyaluronic acid and/or its metal compounds is formed, where the transitional metals content is maximally 10 mg per 1 kg of hyaluronate. The solution is stirred for from 20 minutes to 10 hours at the temperature of 18 to 35°C until a homogeneous solution suitable for spinning is formed. This solution can be prepared under ambient atmosphere or further preferably under inert atmosphere, e.g. nitrogen or argon. Preferably, the fibre is left in the coagulation bath after being spun. Preferably, the fibre is drawn after spinning or its leaving in the coagulation bath.
Hyaluronic acid (HA), like other polysaccharides, does not flux, but wet and wet-dry spinning can be used successfully, where the solution of hyaluronic acid and/or its metal compound is extruded through various types of a nozzle (circular nozzle or slot nozzle or a nozzle of various cross-sections: star-shaped, spherical triangle, and the like) directly into a non-solvent (coagulation bath) where the fibre is formed. We have found out that when a salt of hyaluronic acid or its acid form dissolves in water in the presence of a base, an alkali solution of hyaluronate is formed, and its apparent viscosity depends on the molecular weight ( w ) of the dissolved hyaluronate and this value strongly depends on the time of standing of this solution.
Standing of this solution during time gradually causes the decomposition of hyaluronate molecules and thereby a solution with lower viscosity forms, which can be extruded through the nozzle into the coagulation (spinning) bath, where the so-called non-drawn fibre forms.
However, the most essential fact concerning the preparation of strong (tenacious) As the coagulation bath is acidic, the alkali salt of hyaluronic acid is converted into an acidic form (HA-COOMe → HA-COOH), and during standing of the fibre in this bath, a set of hydrogen bonds is gradually formed, which converts the "free" carboxyl group into a carboxyl group involved in this H-bonds system, and thus the water resistance, i.e. insolubility, of the formed fibre gradually increases, and the strength of this fibre increases.
The presence of the alcohol in the coagulation bath is essential, as at its proper concentration, the fibre does not float on the bath surface but sinks to the bottom and does not paste together.
We have found that the presence of the alcohol in the coagulation bath also fundamentally influences the shape of the hyaluronic acid molecule and thus the fibre strength. In the coagulation bath which comprises acetic acid, water and alcohol, the molecules of hyaluronic acid show a distinctively lower diffusion than in the bath consisting only of acetic acid and water. The fibre can eventually comprise a metal compound coming from the manufacturing process, such as acetates, formates, sulphates, chlorides, fluorides, nitrates, phosphates, hydroxides, or oxides of metals selected from the group comprising lithium, sodium, potassium, calcium, magnesium, copper, manganese, zinc, chromium, iron, and cobalt. These compounds can weakly or strongly interact with hyaluronic acid. In case of zinc, the fibre can also comprise zincates as metal salts.
Another object of the invention is the use of the fibre according to the invention for the preparation of woven and non-woven textiles.
Brief description of the drawings Fig. 1 illustrates a drawn hyaluronic acid fibre prepared according to the example 4 . Fig. 2 illustrates a knitted fabric prepared from a hyaluronic acid fibre (example 4). cN.dtex 1 and ductility of 9 % after conditioning at air relative humidity of 65 % was obtained.
From the fibre obtained in this way (Fig. 1 ), knitted fabric ( Fig. 2) and fabric ( Fig. 3) were made. Example 6 2 ml of water solution of NaOH (prepared by introducing 6.4 g of NaOH pellets into 100 ml of water) and 18 ml of H 2 0 (demi pure) were mixed in a 50 ml beaker. 1.6 g of sodium hyaluronate (CPN s.r.o., Dolni Dobrouc, Czech Republic) having the molecular weight of 2.6 MDa (determined by SEC-MALLS method) was slowly added at very intensive stirring (1400 rpm) on the magnetic mixer Heidolph. The agitator revolutions were gradually decreased with the increasing viscosity of the solution to keep the stirring of the solution. This solution in which the concentration of hyaluronate is 7.4 % has been stirred for 18 hours to ensure the complete homogeneity. Then it was poured into a 20ml syringe which was left open for a short time (few minutes) to remove bubbles an then the syringe was closed with a piston.
The coagulation bath was prepared by mixing propane-2-ol and 98% acetic acid in the ratio of 1:4 by volume, and pouring this mixture into a high graduated cylinder of the volume of 500 ml.
The syringe was placed into a linear pump Nexus 5000 from the Chemyx company. A 45cm
hose with Luer-lock system was joined to the syringe, and the needle Hamilton N NEEDLE (26/51/3) with the mouth diameter of 0.26 mm was joined to the end of the hose. The needle was immersed into the bath, approximately 5 cm under the surface. Then the spinning process was started. The fibre was dropping to the bottom of the graduated cylinder on the trajectory of about 35 cm (helical movement), where it stocked gradually. During this process, a the fibre can aglutinate together, but after removing it from the coagulation bath, the fibre can be untwisted very easily. After finishing the spinning process, the end of the fibre was caught and the fibre was removed from the bath to a perforated reel, where it dried gradually and volatile precipitants evaporated.
The resulting fibre (Fig. 4) consists of hyaluronic acid having the molecular weight of 170.5 kDa and polydispersity of 1.751 (determined by SEC-MALLS method). The fibre strength was measured on the break test machine Instron 3343. Experiments with various kinds of alcohols in the coagulation bath were carried out. The alcohols methanol, glycol, 1,2-propandiol, 2-propanol and ethanol were used, and from these, methanol, ethanol and 2-propanol appeared to be most preferred, mainly for technical reasons (easy removal form the bath, fibre untwisting, and the like). The table implies that the fibre strength is enhanced thanks to the addition of alcohol into the coagulation bath.
Example 8 (comparative example)
In the 50 ml beaker, 2 ml of an aqueous solution of NaOH (prepared by adding 6.4 g of NaOH pellets into 100 ml of water) and 18 ml of H 0 (demi pure) were mixed. 1.6 g of sodium hyaluronate (CPN s.r.o., Dolni Dobrouc, Czech Republic) having the molecular weight of 2.6 MDa (determined by SEC-MALLS method) was slowly added at very intensive stirring (1400 rpm) on the magnetic mixer Heidolph. The agitator revolutions were gradually decreased with the increasing viscosity of the solution to keep the stirring of the solution. This solution, where the concentration of hyaluronate is 7.4 % , has been stirred for 18 hours to ensure the complete homogeneity. Then it was poured into a 20ml syringe which was left open for a short time (few minutes) to remove bubbles and then the syringe was closed with a piston.
The coagulation bath was prepared according to the description in Table 4 in a high graduated cylinder of the volume of 500 ml. The syringe was placed into a linear pump Nexus 5000 from the Chemyx company. A 45cm hose with Luer-lock system was joined to the syringe, and the needle Hamilton N NEEDLE (26/51/3) with the mouth diameter of 0.26 mm was joined to the end of the hose. The needle was immersed into the bath, approximately 5 cm under the surface. The parameters of the syringe and the feeding speed were set in the pump. Then the spinning process was started. The results of the influence of individual acids are summarized in Table 4 . Table 4 All the ratios of compositions are volume ratios. H 3 PO4 was 85%, HCI 36%, and HNO3 68%.
Citric acid was prepared as a saturated solution ( .3 kg/I H 2 0).
The above mentioned table implies that of all the acids tested, only H 3 P0 is suitable, as it enables the formation and maintaining of the fibre, which can be subsequently used for manufacturing a non-woven fabric. Further, it is obvious, that the presence of water in the coagulation bath deteriorates the fibre formation process. Example 1 1
The method described in Example 4 was used for the preparation of a fibre (drawn, dried) which had the initial strength of 2.829 cN/dtex (0.3539 GPa) -elongation at break of 9 % . This fibre was immersed in a metalization bath having the composition: 2 g of chrome alum
(KCr(S0 ) . 12 2 0), 650 ml of methanol p.a., 350 ml of pure 98% formic acid and 10 ml of water. The fibre was left in this bath at room temperature for 24 hours. After this time, the fibre winding was removed from the bath, washed with methanol and dried at room temperature. The strength of the resulting fibre is 1.097 cN/dtex (0,1954 GPa) , elongation at break is 3 % .
Cr 3+ content = 990.9 [mg.kg ' ] .
Example 12
The method described in Example 4 was used for the preparation of a fibre (drawn, dried) which had the initial strength of 1.715 cN/dtex (0.2290 GPa) -elongation at break of 6 % . This fibre was immersed in a bath having the composition: 2 g of cupric sulphate (CuS0 .5H 2 0), 650 ml of methanol p.a., 350 ml of pure 98% formic acid and 10 ml of water. The fibre was left in this bath at room temperature for 24 hours. After this time, the fibre winding was removed from the bath, washed with methanol and dried at room temperature. The strength of the resulting fibre is 1.197 cN/dtex (0.1826 GPa), elongation at break is 4 % . Mechanical parameters of the fibre: strength 1.93 cN/dtex (0.377 GPa), elongation at break 6 % . (pentahydrate) in the mixture of 650 ml of methanol p.a. and 350 ml of 98% pure formic acid.
The standing time therein was 2 1 days. After removing from the metalization bath, the fibre was washed with methanol and dried at room temperature.
The obtained fibre was soluble in water at room temperature. The Table below shows the comparison with the fibres prepared according to the Examples 3 and 4 , subjected to the same drawing. CLAIMS 1 . A method of preparation of fibres based on hyaluronic acid and/or a metal compound thereof characterized by that a spinning aqueous solution containing hyaluronic acid and/or a metal compound thereof is prepared which is subsequently spun in a coagulation bath containing an alcohol and an acid, then the fibre is washed and after washing, the fibre is dried.
Content of Cu
2 . The method according to claim 1, characterized by that after spinning in the coagulation bath, at least one of the steps selected from the group comprising maturation of the fibre in the coagulation bath for 1 second to 48 hours and drawing of the fibre at the drawing ratio within the range of . 1 to 7 is performed. 4 . The method according to any of the preceding claims, characterized by that the spinning solution contains the hyaluronic acid and/or a metal compound thereof and a base selected from the group comprising LiOH, NaOH, KOH, Li 2 C0 3 , Na 2 C0 3 , K 2 C0 , LiHC0 , NaHC0 3 and KHC0 3 , the coagulation bath contains an alcohol selected from the group comprising methanol, ethanol, 1-propanol and 2-propanol, and an acid selected from the group comprising formic acid, acetic acid, propionic acid or a mixture thereof, the washing is performed by means of an alcohol selected from the group comprising methanol, ethanol, 1-propanol and 2-propanol, and the drying is performed by standing in air or in a nitrogen or C0 atmosphere for 1 hour to 5 days at the temperature of 20 to 80°C.
5 . The method according to any of the preceding claims, characterized by that the hyaluronic acid and/or a metal compound thereof has the molecular weight within the range of 100 kDa to 3 MDa and the metal compound of the hyaluronic acid is selected from the group comprising Li * , Na K + , Ca 2+ , Mg 2+ salt.
6 . The method according to any of the preceding claims, characterized by that the spinning solution is prepared under an inert atmosphere. 11. The method according to any of the claims 9 and 10, characterized by that first a solution of a base having the concentration of 0,001 to 10 N is prepared, into this solution the hyaluronic acid and/or a metal compound thereof is gradually introduced while stirring in order to obtain a solution having the concentration of 0,01 to 8 % wt. of the hyaluronic acid and/or a metal compound thereof, then a metal salt is added to this solution so that the maximum amount of the transition metal is 10 mg 1 kg of the total amount of the hyaluronic acid and/or a metal compound thereof, then the resulting solution is stirred for 20 minutes to 10 hours at the temperature of 8 to 35 C until a homogenous solution is formed.
12. The method according to any of the claims 1 to 7, characterized by that the coagulation bath contains an alcohol and an acid and one or more metal salts. thereof characterized by that a spinning aqueous solution containing hyaluronic acid and/or a metal compound thereof is prepared which is subsequently spun in a coagulation bath containing 1 to 99 % wt. of an alcohol, 1 to 99 % wt. of an acid and not more than 0 % wt. of water, wherein the temperature of the coagulation bath is 18 to 30°C, and then the fibre is washed and after washing, the fibre is dried.
2 . The method according to claim 1, characterized by that after spinning in the coagulation bath, at least one of the steps selected from the group comprising maturation of the fibre in the coagulation bath for 1 second to 48 hours and drawing of the fibre at the drawing ratio within the range of 1.1 to 7 is performed.
3 . The method according to any of the preceding claims, characterized by that the spinning solution of the hyaluronic acid and/or a metal compound thereof is prepared, containing 0.001 to 10 N of a base and 0.01 to 8 % wt. of the hyaluronic acid and/or a metal compound thereof, then the solution is spun through the nozzle into the coagulation bath containing 1 to 99 % wt. of alcohol, 1 to 99 % wt. of an acid and not more than 10 % wt. of water, subsequently the fibre is washed with alcohol and dried.
4 . The method according to any of the preceding claims, characterized by that the spinning solution contains the hyaluronic acid and/or a metal compound thereof and a base selected from the group comprising LiOH, NaOH, KOH, Li 2 C0 , Na C0 , K 2 C0 3 , LiHC0 , NaHCO. and KHC0 3 , the coagulation bath contains an alcohol selected from the group comprising methanol, ethanol, 1-propanol and 2-propanol, and an acid selected from the group comprising formic acid, acetic acid, propionic acid or a mixture thereof, the washing is performed by means of an alcohol selected from the group comprising methanol, ethanol, 1-propanol and 2-propanol, and the drying is performed by standing in air or in a nitrogen or C0 2 atmosphere for 1 hour to 5 days at the temperature of 20 to 80 C .
5 . The method according to any of the preceding claims, characterized by that the hyaluronic acid and/or a metal compound thereof has the molecular weight within the range of 100 kDa to 3 MDa and the metal compound of the hyaluronic acid is selected from the group comprising Li * , Na", , Ca + , Mg + salt. . The method according to any of the claims 9 and 10, characterized by that first a solution of a base having the concentration of 0,001 to 10 N is prepared, into this solution the hyaluronic acid and/or. a metal compound thereof is gradually introduced while stirring in order to obtain a solution having the concentration of 0,01 to 8 % wt. of the hyaluronic acid and/or a metal compound thereof, then a metal salt is added to this solution so that the maximum amount of the transition metal is 10 g/ kg of the total amount of the hyaluronic acid and/or a metal compound thereof, then the resulting solution is stirred for 20 minutes to 0 hours at the temperature of 18 to 35°C until a homogenous solution is formed.
. The method according to any of the claims 1 to 7 , characterized by that the coagulation bath contains an alcohol and an acid and one or more metal salts. 14. The method according to any of the claims 12 a 13, characterized by that the coagulation bath contains a solution of a calcium salt in the mixture of 5 to 95 % wt. of alcohol, 5 to 95 % wt. of an acid and not more than 0 % wt, of water.
15. The method according to any of the claims 1 to 7 , characterized by that the washed or the washed and dried fibre is inserted into the metalization bath containing a metal salt and an alcohol for 20 minutes to 2 1 days, then it is washed and dried.
. The method according to claim 15, characterized by that the metal salt is selected from the group comprising acetates, formates, chlorides, sulphates, fluorides, nitrates and hydrates of these salts, of metals selected from the group comprising n + , Ca 2+ , Cr 3 , Fe + , Fe 3+ , Co + , Co 3+ , Cu 2+ , Zn + and mixtures thereof and the alcohol is selected from the group comprising methanol, ethanol, 1-propanol and 2-propanol.
17. The method according to any of the claims 15 or 16, characterized by that the metalization bath contains a metal salt having the concentration of 5.10 5 to 1.10 M, 1 to 99 % of alcohol, 1 to 99 % wt, of an acid selected from the group comprising formic acid, acetic acid, propionic acid or a mixture thereof, and not more than 10 % wt. of water.
18. The method according to any of the claims 15 or 16, characterized by that the metalization bath contains a metal salt having the concentration of 6.10 " to 1.10 ' 1 M , 1 to 99 % of alcohol and not more than 10 % wt. of water.
. The method according to claim 18, characterized by that the metalization bath further contains a base selected from the group comprising LiOH, NaOH, KOH, Li C0 3 , Na C0 3 , K C0 , LiHC0 3 NaHC0 and KHC0 in the concentration of 5.10 to 1 N . * Special categories of cited documents : "T" later document published after the international filing date o r priority date and not in conflict with the application but "A" document defining the general state of the art which is not cited to understand the principle o r theory underlying the considered to b e of particular relevance invention "E" earlier document but published o n o r after the international "X" document of particular relevance; the claimed invention filing date cannot be considered novel o r cannot b e considered to "L" documentwhich may throw doubts o n priority claim(s) o r involve a n inventive step when the document is taken alone which is cited to establish the publication date of another "Y" document of particular relevance; the claimed invention citation o r other special reason (as specified) cannot be considered to involve a n inventive step when the "O" document referring to a n oral disclosure, use, exhibition o r document is combined with one o r more other such docu¬ other means ments, such combination being obvious to a person skilled "P" document published prior to the international filing date but in the art. 
